Risk of acquiring extended-spectrum β-lactamase-producing Klebsiella species and escherichia coli from prior room occupants in the intensive care unit

Infection Control and Hospital Epidemiology

Volumn 34, Issue 5 SPL, 2013, Pages 453-458

  Ajao, Adebola O ^a   Kristie Johnson, J ^a   Harris, Anthony D ^a   Zhan, Min ^a   McGregor, Jessina C ^b   Thom, Kerri A ^a   Furuno, Jon P ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b OREGON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; CEFOTAXIME; CEFTAZIDIME; CLAVULANIC ACID;

ADULT; ARTICLE; BACTERIAL STRAIN; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; DRUG EXPOSURE; ESCHERICHIA COLI; FEMALE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MICROBIAL COLONIZATION; MICROBIOLOGY; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; RETROSPECTIVE STUDY; RISK; UNIVARIATE ANALYSIS;

ACADEMIC MEDICAL CENTERS; ADULT; AGED; ANAL CANAL; BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; CROSS INFECTION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; INTENSIVE CARE UNITS; KLEBSIELLA; KLEBSIELLA INFECTIONS; MALE; MIDDLE AGED; PATIENT ADMISSION; PATIENT DISCHARGE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84876083102     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/670216     Document Type: Article

References (32)

1. Paterson DL, Bonomo RA. Extended-spectrum b-lactamases: a clinical update. Clin Microbiol Rev 2005;18:657-686.
2. Ramphal R, Ambrose PG. Extended-spectrum b-lactamases and clinical outcomes: current data. Clin Infect Dis 2006;42:164-172.
3. Ho J, Tambyah PA, Paterson DL. Multiresistant gram-negative infections: a global perspective. Curr Opin Infect Dis 2010;23: 546-553.
4. Flaherty JP, Weinstein RA. Nosocomial infection caused by antibiotic-resistant organisms in the intensive-care unit. Infect Control Hosp Epidemiol 1996;17:236-248.
5. Shaughnessy MK, Micielli RL, DePestel DD, et al. Evaluation of hospital room assignment and acquisition of Clostridium difficile infection. Infect Control Hosp Epidemiol 2011;32:201-206.
6. Nseir S, Blazejewski C, Lubret R, Wallet F, Courcol R, Durocher A. Risk of acquiring multidrug-resistant gram-negative bacilli from prior room occupants in the intensive care unit. Clin Microbiol Infect 2010;17:1201-1208.
7. Drees M, Snydman DR, Schmid CH, et al. Antibiotic exposure and room contamination among patients colonized with vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 2008;29:709-715.
8. Huang SS, Datta R, Platt R. Risk of acquiring antibiotic-resistant bacteria from prior room occupants. Arch Intern Med 2006;166: 1945-1951.
9. Kac G, Podglajen I, Vaupre S, Colardelle N, Buu-Hof A, Gutmann L. Molecular epidemiology of extended-spectrum b-lactamase-producing Enterobacteriaceae isolated from environmental and clinical specimens in a cardiac surgery intensive care unit. Infect Control Hosp Epidemiol 2004;25:852-855.
10. Hobson RP, MacKenzie FM, Gould IM. An outbreak of multiply-resistant Klebsiella pneumoniae in the Grampian region of Scotland. J Hosp Infect 1996;33:249-262.
11. Harris AD, Kotetishvili M, Shurland S, et al. How important is patient-to-patient transmission in extended-spectrum b-lactamase Escherichia coli acquisition. Am J Infect Control 2007;35: 97-101.
12. Harris AD, Perencevich EN, Johnson JK, et al. Patient-to-patient transmission is important in extended-spectrum b-lactamaseproducing Klebsiella pneumoniae acquisition. Clin Infect Dis 2007;45:1347-1350.
13. Lautenbach E, Harris AD, Perencevich EN, Nachamkin I, Tolomeo P, Metlay JP. Test characteristics of peri-rectal and rectal swab compared to stool sample for detection of fluoroquinolone-resistant Escherichia coli in the gastrointestinal tract. Antimicrob Agents Chemother 2005;49:798-800.
14. Sehulster L, Chinn RY; Centers for Disease Control and Prevention (CDC), Healthcare Infection Control Practices Advisory Committee (HICPAC). Guidelines for environmental infection control in health-care facilities: recommendations of the CDC and HICPAC. MMWR Recomm Rep 2003;52:1-42.
15. McGregor JC, Kim PW, Perencevich EN, et al. Utility of the chronic disease score and Charlson comorbidity index as comorbidity measures for use in epidemiologic studies of antibiotic-resistant organisms. Am J Epidemiol 2005;161:483-493.
16. Furuno JP, Harris AD, Wright MO, et al. Prediction rules to identify patients with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci upon hospital admission. Am J Infect Control 2004;32:436-440.
17. Furuno JP, McGregor JC, Harris AD, et al. Prevalence of methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii in a long-term care facility. Arch InternMed 2006;166(5): 580-585.
18. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-619.
19. Bonten MJ, Slaughter S, Ambergen AW, et al. The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med 1998;158:1127-1132.
20. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 19th informational supplement. Clinical and Laboratory Standards Institute, 2009.
21. Johnson JK, Smith G, Lee MS, et al. The role of patient-topatient transmission in the acquisition of imipenem-resistant Pseudomonas aeruginosa colonization in the intensive care unit. J Infect Dis 2009;200:900-905.
22. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233-2239.
23. Williams RL. A note on robust variance estimation for clustercorrelated data. Biometrics 2000;56:645-646.
24. D'Agata E, Venkataraman L, DeGirolami P, Weigel L, Samore M, Tenover F. The molecular and clinical epidemiology of Enterobacteriaceae-producing extended-spectrum b-lactamase in a tertiary care hospital. J Infect 1998;36:279-285.
25. Harris AD, McGregor JC, Johnson JA, et al. Risk factors for colonization with extended-spectrum b-lactamase-producing bacteria and intensive care unit admission. Emerg Infect Dis 2007; 13:1144-1149.
26. Ben-Ami R, Schwaber MJ, Navon-Venezia S, et al. Influx of extended-spectrum b-lactamase-producing Enterobacteriaceae into the hospital. Clin Infect Dis 2006;42:925-934.
27. Pessoa-Silva CL, Meurer Moreira B, Camara Almeida V, et al. Extended-spectrum b-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit: risk factors for infection and colonization. J Hosp Infect 2003;53:198-206.
28. Bisson G, Fishman NO, Patel JB, Edelstein PH, Lautenbach E. Extended-spectrum b-lactamase-producing Escherichia coli and Klebsiella species: risk factors for colonization and impact of antimicrobial formulary interventions on colonization prevalence. Infect Control Hosp Epidemiol 2002;23:254-260.
29. Ariffin H, Navaratnam P, Mohamed M, et al. Ceftazidimeresistant Klebsiella pneumoniae bloodstream infection in children with febrile neutropenia. Int J Infect Dis 2000;4:21-25.
30. Wiener J, Quinn JP, Bradford PA, et al. Multiple antibioticresistant Klebsiella and Escherichia coli in nursing homes. JAMA 1999;281:517-523.
31. Soulier A, Barbut F, Ollivier JM, Petit JC, Lienhart A. Decreased transmission of enterobacteriaceae with extended-spectrum blactamases in an intensive care unit by nursing reorganization. J Hosp Infect 1995;31:89-97.
32. Ajao AO, Harris AD, Roghmann MC, et al. Systematic review of measurement and adjustment for colonization pressure in studies of methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and Clostridium difficile acquisition. Infect Control Hosp Epidemiol 2011;32:481-489.